CELEX ID: 32010R1238

--- ENGLISH ---

Document:
$en_document

Summary:
$en_summary

--- DANISH ---

Document:
31.12.2010
DA
Den Europæiske Unions Tidende
L 348/36
EUROPA-PARLAMENTETS OG RÅDETS FORORDNING (EU) Nr. 1238/2010
af 15. december 2010
om ændring af bilag I til forordning (EØF) nr. 2658/87 for så vidt angår sikring af toldfri behandling af visse aktive farmaceutiske ingredienser med internationale ikke-navnebeskyttede navne (INN) fra Verdenssundhedsorganisationen og af visse produkter, der anvendes til fremstilling af farmaceutiske færdigvarer
EUROPA-PARLAMENTET OG RÅDET FOR DEN EUROPÆISKE UNION HAR —
under henvisning til traktaten om Den Europæiske Unions funktionsmåde, særlig artikel 207,
under henvisning til forslag fra Europa-Kommissionen,
efter fremsendelse af udkast til lovgivningsmæssig retsakt til de nationale parlamenter,
efter den almindelige lovgivningsprocedure 
(
1
)
, og
ud fra følgende betragtninger:
(1)
Under forhandlingerne i Uruguayrunden vedtog Fællesskabet og en række lande, at der bør indrømmes toldfri behandling for farmaceutiske varer henhørende under kapitel 30 i det harmoniserede system (HS) og HS-position 2936, 2937, 2939 og 2941 og for nærmere angivne aktive farmaceutiske ingredienser med internationale ikke-navnebeskyttede navne (INN) fra Verdenssundhedsorganisationen samt for nærmere angivne salte, estere og hydrater af sådanne INN og desuden for nærmere angivne farmaceutiske mellemstoffer, der anvendes til produktion og fremstilling af farmaceutiske færdigvarer.
(2)
Resultaterne af drøftelserne som gengivet i referatet blev indarbejdet i deltagernes toldlister, der er bilagt Marrakeshprotokollen til den almindelige overenskomst om told og udenrigshandel (GATT) 1994.
(3)
Deltagerne konkluderede, at repræsentanter for de medlemmer af Verdenshandelsorganisationen (WTO), der deltog i drøftelserne, skulle mødes inden for rammerne af WTO's Råd for Handel med Varer, sædvanligvis mindst én gang hvert tredje år, for at revidere produktdækningen med henblik på ved konsensus at tilføje yderligere farmaceutiske produkter, der ikke længere skal belægges med told.
(4)
Tre sådanne revisioner har fundet sted, og resultatet er, at der er indrømmet behandling med toldfritagelse af yderligere et bestemt antal INN og farmaceutiske mellemstoffer, der bruges til produktion og fremstilling af farmaceutiske færdigvarer, at nogle af disse mellemstoffer er overført til listen over INN, og at listen over nærmere bestemte præfikser og suffikser for salte, estere eller hydrater af INN er blevet udvidet.
(5)
En fjerde revision blev skønnet nødvendig og blev iværksat i 2009. Det blev konkluderet, at der bør indrømmes behandling med toldfritagelse af yderligere et bestemt antal INN og farmaceutiske mellemstoffer, der bruges til produktion og fremstilling af farmaceutiske færdigvarer, at nogle af disse mellemstoffer, der allerede er tilføjet i det farmaceutiske sektorarrangement med efterfølgende ændringer, bør overføres til listen over INN, og at listen over nærmere bestemte præfikser og suffikser for salte, estere eller hydrater af INN bør udvides.
(6)
Ved Rådets forordning (EØF) nr. 2658/87 af 23. juli 1987 om told- og statistiknomenklaturen og den fælles toldtarif 
(
2
)
 blev den kombinerede nomenklatur (KN) indført og den fælles toldtarifs konventionelle toldsatser fastsat.
(7)
Forordning (EØF) nr. 2658/87 bør ændres i overensstemmelse hermed.
(8)
For at sikre, at de i denne forordning fastsatte foranstaltninger anvendes fra den 1. januar 2011, bør denne forordning træde i kraft på dagen efter offentliggørelsen —
VEDTAGET DENNE FORORDNING:
Artikel 1
Bilag 3, 4 og 6 i afsnit II i del III i bilag I til forordning (EØF) nr. 2658/87 (lister over farmaceutiske stoffer, som opfylder betingelserne for behandling med toldfritagelse) ændres således:
(1)
Fra den 1. januar 2011 indrømmer Unionen toldfritagelse for de i bilag I angivne INN.
(2)
Listen over præfikser og suffikser, som i forbindelse med de anførte INN, der er tilføjet i det farmaceutiske sektorarrangement med senere ændringer, beskriver de salte, estere eller hydrater af INN, som også er berettigede til behandling med toldfritagelse, under forudsætning af at disse kan tariferes i samme 6-cifrede HS-underposition som det tilsvarende INN, ændres fra den 1. januar 2011 som anført i bilag II.
(3)
Fra den 1. januar 2011 indrømmer Unionen toldfritagelse for de farmaceutiske mellemstoffer, der anvendes til produktion og fremstilling af de farmaceutiske færdigvarer, og som er opført i bilag III.
(4)
Fra den 1. januar 2011 skal de farmaceutiske mellemstoffer, der er opført i bilag IV, slettes på listen over de stoffer, som er fritaget for told.
Artikel 2
Denne forordning træder i kraft dagen efter offentliggørelsen i 
Den Europæiske Unions Tidende
.
Den anvendes fra den 1. januar 2011.
Denne forordning er bindende i alle enkeltheder og gælder umiddelbart i hver medlemsstat.
Udfærdiget i Strasbourg, den 15. december 2010.
På Europa-Parlamentets vegne
J. BUZEK
Formand
På Rådets vegne
O. CHASTEL
Formand
(
1
)
  Europa-Parlamentets holdning af 23.11.2010 (endnu ikke offentliggjort i EUT) og Rådets afgørelse af 10.12.2010.
(
2
)
  
            
EFT L 256 af 7.9.1987, s. 1
.
BILAG I
Liste over internationale ikke-navnebeskyttede navne (INN), der skal tilføjes på listen over produkter, der er fritaget for told, i bilag 3 til bilag I til forordning (EØF) nr. 2658/87
KN-kode
CAS RN
Betegnelse
2842 90 80
119175-48-3
fermagat
2843 90 90
759457-82-4
padeliporfin
2844 40 30
123748-56-1
iodfiltinsyre (
)
2904 10 00
21668-77-9
eprodisat
2906 19 00
199798-84-0
elocalcitol
2909 30 90
24150-24-1
terameprocol
2916 19 95
81485-25-8
peretinoin
2916 39 00
51543-40-9
tarenflurbil
2918 19 98
174022-42-5
bevirimat
2919 90 00
258516-89-1
fospropofol
2920 90 85
163133-43-5
naproxcinod
2921 19 99
3687-18-1
tramiprosat
2922 19 85
68392-35-8
afimoxifen
2922 19 85
753449-67-1
ronacaleret
2922 29 00
433265-65-7
faxeladol
2922 50 00
121524-08-1
amibegron
2922 50 00
329773-35-5
cinaciguat
2922 50 00
643094-49-9
fasobegron
2923 10 00
856676-23-8
cholinfenofibrat
2924 29 98
847353-30-4
arbaclofenplacarbil
2924 29 98
194785-19-8
bedoradrin
2924 29 98
194085-75-1
carisbamat
2924 29 98
254750-02-2
emricasan
2924 29 98
355129-15-6
eprotirom
2924 29 98
402567-16-2
firategrast
2924 29 98
478296-72-9
gabapentinenacarbil
2924 29 98
15866-90-7
incyclinid
2924 29 98
202844-10-8
indantadol
2924 29 98
96847-55-1
levomilnacipran
2924 29 98
608137-32-2
lisdexamfetamin
2924 29 98
652990-07-3
milveterol
2924 29 98
181816-48-8
ombrabulin
2924 29 98
289656-45-7
senicapoc
2925 19 95
19171-19-8
pomalidomid
2928 00 90
22033-87-0
olesoxim
2928 00 90
2675-35-6
sivifen
2928 00 90
816458-31-8
tecovirimat
2928 00 90
238750-77-1
tosedostat
2928 00 90
149647-78-9
vorinostat
2929 90 00
31645-39-3
palifosfamid
2930 90 99
608141-41-9
apremilast
2930 90 99
216167-92-9
camobucol
2930 90 99
211513-37-0
dalcetrapib
2930 90 99
69819-86-9
darinaparsin
2930 90 99
488832-69-5
elesclomol
2930 90 99
216167-95-2
elsibucol
2930 90 99
168682-53-9
ezatiostat
2930 90 99
58569-55-4
metenkefalin
2930 90 99
887148-69-8
monepantel
2930 90 99
603139-19-1
odanacatib
2930 90 99
162520-00-5
salirasib
2930 90 99
216167-82-7
succinobucol
2930 90 99
125961-82-2
tipelukast
2931 00 99
125973-56-0
amsilaroten
2932 19 00
253128-41-5
eribulin
2932 19 00
186953-56-0
pafuramidin
2932 29 85
195883-06-8
omtriptolid
2932 99 00
664338-39-0
arterolan
2932 99 00
183133-96-2
cabazitaxel
2932 99 00
401925-43-7
celivaron
2932 99 00
461432-26-8
dapagliflozin
2932 99 00
118457-15-1
dexnebivolol
2932 99 00
156294-36-9
larotaxel
2932 99 00
118457-16-2
levonebivolol
2932 99 00
83461-56-7
mifamurtid
2932 99 00
117570-53-3
vadimezan
2933 19 90
496775-61-2
eltrombopag
2933 19 90
206884-98-2
niraxostat
2933 19 90
410528-02-8
palovaroten
2933 19 90
376592-42-6
totrombopag
2933 29 90
183659-72-5
catramilast
2933 29 90
944263-65-4
demiditraz
2933 29 90
867153-61-5
dulanermin
2933 29 90
320367-13-3
lixisenatid
2933 29 90
698389-00-3
rolipoltid
2933 29 90
697766-75-9
velafermin
2933 39 99
147084-10-4
alcaftadin
2933 39 99
54-96-6
amifampridin
2933 39 99
249921-19-5
anamorelin
2933 39 99
319460-85-0
axitinib
2933 39 99
208110-64-9
befiradol
2933 39 99
330942-05-7
betrixaban
2933 39 99
201034-75-5
daporinad
2933 39 99
209783-80-2
entinostat
2933 39 99
412950-27-7
goxalapladib
2933 39 99
218791-21-0
imisopasemmangan
2933 39 99
103129-82-4
levamlodipin
2933 39 99
154357-42-3
levonadifloxacin
2933 39 99
108147-54-2
migalastat
2933 39 99
453562-69-1
motesanib
2933 39 99
139145-27-0
parogrelil
2933 39 99
459856-18-9
pexacerfont
2933 39 99
706779-91-1
pimavanserin
2933 39 99
362665-56-3
pitolisant
2933 39 99
861151-12-4
rosonabant
2933 39 99
701977-09-5
taranabant
2933 39 99
189950-11-6
tropantiol
2933 39 99
793655-64-8
vapitadin
2933 39 99
139290-65-6
volinaserin
2933 49 90
141388-76-3
besifloxacin
2933 49 90
697761-98-1
elvitegravir
2933 49 90
185055-67-8
ferroquin
2933 49 90
445041-75-8
intiquinatin
2933 49 90
378746-64-6
nemonoxacin
2933 49 90
245765-41-7
ozenoxacin
2933 49 90
412950-08-4
rilapladib
2933 49 90
871224-64-5
almorexant
2933 49 90
863029-99-6
balamapimod
2933 49 90
698387-09-6
neratinib
2933 49 90
154652-83-2
tezampanel
2933 49 90
128253-31-6
veliflapon
2933 59 95
791828-58-5
aderbasib
2933 59 95
840486-93-3
adipiplon
2933 59 95
850649-61-5
alogliptin
2933 59 95
859212-16-1
bafetinib
2933 59 95
380843-75-4
bosutinib
2933 59 95
839712-12-8
cariprazin
2933 59 95
414910-27-3
casopitant
2933 59 95
288383-20-0
cediranib
2933 59 95
849550-05-6
cevipabulin
2933 59 95
827318-97-8
danusertib
2933 59 95
356057-34-6
darapladib
2933 59 95
501000-36-8
dutacatib
2933 59 95
247257-48-3
fimasartan
2933 59 95
3432-99-3
folitixorin
2933 59 95
668270-12-0
linagliptin
2933 59 95
441798-33-0
macitentan
2933 59 95
641571-10-0
nilotinib
2933 59 95
763113-22-0
olaparib
2933 59 95
686344-29-6
otenabant
2933 59 95
625115-55-1
riociguat
2933 59 95
486460-32-6
sitagliptin
2933 59 95
425637-18-9
sotrastaurin
2933 59 95
309913-83-5
talmapimod
2933 59 95
113857-87-7
talotrexin
2933 59 95
274693-27-5
ticagrelor
2933 59 95
306296-47-9
vicriviroc
2933 69 80
775351-65-0
imeglimin
2933 79 00
461443-59-4
aplaviroc
2933 79 00
189691-06-3
bremelanotid
2933 79 00
813452-18-5
carmegliptin
2933 79 00
405169-16-6
dovitinib
2933 79 00
536748-46-6
eribaxaban
2933 79 00
473289-62-2
ilepatril
2933 79 00
180694-97-7
mimopezil
2933 79 00
579475-18-6
orvepitant
2933 79 00
449811-01-2
pamapimod
2933 79 00
248282-01-1
paquinimod
2933 79 00
380917-97-5
perampanel
2933 79 00
552292-08-7
rolapitant
2933 79 00
425386-60-3
semagacestat
2933 79 00
515814-01-4
voclosporin
2933 99 80
481629-87-2
aleplasinin
2933 99 80
394730-60-0
boceprevir
2933 99 80
649735-63-7
brivanibalaninat
2933 99 80
483369-58-0
denagliptin
2933 99 80
284019-34-7
denibulin
2933 99 80
481631-45-2
diaplasinin
2933 99 80
272105-42-7
disitertid
2933 99 80
227318-71-0
epetirimod
2933 99 80
259793-96-9
favipiravir
2933 99 80
871576-03-3
flovagatran
2933 99 80
229305-39-9
golotimod
2933 99 80
258818-34-7
larazotid
2933 99 80
571170-77-9
laropiprant
2933 99 80
616202-92-7
lorcaserin
2933 99 80
868771-57-7
melogliptin
2933 99 80
803712-67-6
obatoclax
2933 99 80
404950-80-7
panobinostat
2933 99 80
625114-41-2
piragliatin
2933 99 80
74847-35-1
pyronaridin
2933 99 80
872178-65-9
rabeximod
2933 99 80
355151-12-1
rotigaptid
2933 99 80
497221-38-2
rusalatid
2933 99 80
187602-11-5
sofigatran
2933 99 80
227318-75-4
sotirimod
2933 99 80
402957-28-2
telaprevir
2933 99 80
848084-83-3
tigapotid
2933 99 80
393105-53-8
tiplasinin
2933 99 80
620948-93-8
vabicaserin
2933 99 80
794466-70-9
vernakalant
2934 10 00
544417-40-5
capadenoson
2934 10 00
302962-49-8
dasatinib
2934 10 00
223132-37-4
inolitazon
2934 10 00
241479-67-4
isavuconazol
2934 10 00
338990-84-4
isavuconazoniumchlorid
2934 10 00
607723-33-1
lobeglitazon
2934 10 00
280782-97-0
managlinatdialanetil
2934 10 00
790299-79-5
masitinib
2934 10 00
223673-61-8
mirabegron
2934 10 00
501948-05-6
rosabulin
2934 10 00
447406-78-2
sodelglitazar
2934 10 00
760937-92-6
teneligliptin
2934 20 80
848344-36-5
bentamapimod
2934 20 80
870093-23-5
talarozol
2934 99 90
320345-99-1
aclidiniumbromid
2934 99 90
222551-17-9
adoprazin
2934 99 90
207623-20-9
agatolimod
2934 99 90
475479-34-6
aleglitazar
2934 99 90
870524-46-2
amolimogenbepiplasmid
2934 99 90
875446-37-0
anacetrapib
2934 99 90
250386-15-3
apadenoson
2934 99 90
541550-19-0
apilimod
2934 99 90
160707-69-7
apricitabin
2934 99 90
147403-03-0
azilsartan
2934 99 90
863031-21-4
azilsartanmedoxomil
2934 99 90
757942-43-1
bederocin
2934 99 90
627861-07-8
beperminogenperplasmid
2934 99 90
959961-96-7
bevasiranib
2934 99 90
769901-96-4
capeserod
2934 99 90
868540-17-4
carfilzomib
2934 99 90
872847-66-0
cenersen
2934 99 90
80295-38-1
conestat alfa
2934 99 90
903916-27-8
custirsen
2934 99 90
187865-22-1
derquantel
2934 99 90
134379-77-4
dexelvucitabin
2934 99 90
247046-52-2
dilopetin
2934 99 90
480449-70-5
edoxaban
2934 99 90
188181-42-2
elacytarabin
2934 99 90
98819-76-2
esreboxetin
2934 99 90
763903-67-9
fosalvudintidoxil
2934 99 90
172673-20-0
fosaprepitant
2934 99 90
522664-63-7
ibodutant
2934 99 90
405159-59-3
idrabiotaparinuxnatrium
2934 99 90
188116-07-6
imepitoin
2934 99 90
335619-18-6
inakalant
2934 99 90
1391-36-2
lancovutid
2934 99 90
189059-71-0
lapaquistat
2934 99 90
327026-93-7
lensiprazin
2934 99 90
170632-47-0
lificiguat
2934 99 90
852313-25-8
litenimod
2934 99 90
1000120-98-8
mipomersen
2934 99 90
62253-63-8
nepidermin
2934 99 90
26833-87-4
omacetaxinmepesuccinat
2934 99 90
269718-84-5
pardoprunox
2934 99 90
219923-85-0
pramiconazol
2934 99 90
377727-87-2
preladenant
2934 99 90
524684-52-4
prinaberel
2934 99 90
865311-47-3
quarfloxin
2934 99 90
869884-78-6
radezolid
2934 99 90
496054-87-6
radiprodil
2934 99 90
518048-05-0
raltegravir
2934 99 90
787548-03-2
regrelor
2934 99 90
820957-38-8
retosiban
2934 99 90
572924-54-0
ridaforolimus
2934 99 90
128517-07-7
romidepsin
2934 99 90
93265-81-7
ropidoxuridin
2934 99 90
151823-14-2
sapacitabin
2934 99 90
379231-04-6
saracatinib
2934 99 90
791635-59-1
simotaxel
2934 99 90
119567-79-2
taribavirin
2934 99 90
332012-40-5
telatinib
2934 99 90
925681-61-4
trabedersen
2934 99 90
189003-92-7
trelanserin
2934 99 90
296251-72-4
velimogenaliplasmid
2934 99 90
904302-98-3
viquidacin
2934 99 90
872525-61-6
votucalis
2934 99 90
221877-54-9
zotarolimus
2935 00 90
197904-84-0
apricoxib
2935 00 90
769169-27-9
begacestat
2935 00 90
414864-00-9
belinostat
2935 00 90
313682-08-5
brecanavir
2935 00 90
839673-52-8
cevoglitazar
2935 00 90
358970-97-5
drinabant
2935 00 90
865200-20-0
giripladib
2935 00 90
464213-10-3
ibipinabant
2935 00 90
173424-77-6
laromustin
2935 00 90
398507-55-6
lodenafilcarbonat
2935 00 90
136564-68-6
masilukast
2935 00 90
170569-88-7
mavacoxib
2935 00 90
862189-95-5
mirodenafil
2935 00 90
439687-69-1
nelivaptan
2935 00 90
691852-58-1
nesbuvir
2935 00 90
778576-62-8
oglemilast
2935 00 90
444731-52-6
pazopanib
2935 00 90
362505-84-8
relacatib
2935 00 90
243984-11-4
resatorvid
2935 00 90
519055-62-0
tasisulam
2935 00 90
186497-07-4
zibotentan
2936 29 00
104121-92-8
eldecalcitol
2936 29 00
31690-09-2
levomefolinsyre
2937 19 00
782500-75-8
albiglutid
2937 19 00
348119-84-6
obinepitid
2937 19 00
295350-45-7
ozarelix
2937 19 00
275371-94-3
taspoglutid
2937 19 00
218949-48-5
tesamorelin
2937 19 00
22006-64-0
tridecactid
2937 22 00
132245-57-9
dexamethasoncipecilat
2937 22 00
397864-44-7
fluticasonfuroat
2937 29 00
211254-73-8
lonaprisan
2937 50 00
333963-42-1
cobiproston
2937 50 00
172740-14-6
posaraprost
2937 90 00
834153-87-6
elagolix
2937 90 00
609799-22-6
tasimelteon
2937 90 00
342577-38-2
velneperit
2939 19 00
73232-52-7
methylnaltrexonbromid
2939 59 00
136199-02-5
rolofyllin
2939 99 00
850607-58-8
darotropiumbromid
2939 99 00
187852-63-7
delimotecan
2940 00 00
9007-72-1
ferricarboxymaltose
2940 00 00
442201-24-3
remogliflozinetabonat
2940 00 00
408504-26-7
sergliflozinetabonat
2941 90 00
467214-20-6
alvespimycin
2941 90 00
677017-23-1
berubicin
2941 90 00
229016-73-3
ceftarolinfosamil
2941 90 00
318498-76-9
flopristin
2941 90 00
145435-72-9
gamithromycin
2941 90 00
325965-23-9
linopristin
2941 90 00
857402-23-4
retaspimycin
2941 90 00
305841-29-6
sagopilon
2941 90 00
75747-14-7
tanespimycin
2941 90 00
328898-40-4
tildipirosin
2941 90 00
222400-20-6
tomopenem
2941 90 00
63409-12-1
tylvalosin
3001 90 91
9041-08-1
semuloparinnatrium
3002 10 91
792921-10-9
abagovomab
3002 10 91
910649-32-0
anrukinzumab
3002 10 91
648904-28-3
bavituximab
3002 10 91
402710-27-4
(let kæde)
402710-25-2
(tung kæde)
canakinumab
3002 10 99
945228-49-9
citatuzumabbogatox
3002 10 91
880486-59-9
dacetuzumab
3002 10 91
615258-40-7
denosumab
3002 10 91
762260-74-2
efungumab
3002 10 91
89957-37-9
gantenerumab
3002 10 91
680188-33-4
ibalizumab
3002 10 91
477202-00-9
ipilimumab
3002 10 91
640735-09-7
iratumumab
3002 10 91
845816-02-6
lexatumumab
3002 10 91
903512-50-5
lucatumumab
3002 10 91
899796-83-9
milatuzumab
3002 10 91
677010-34-3
motavizumab
3002 10 91
676258-98-3
naptumomabestafenatox
3002 10 91
828933-51-3
nimotuzumab
3002 10 91
949142-50-1
obinutuzumab
3002 10 91
637334-45-3
ocrelizumab
3002 10 91
881191-44-2
otelixizumab
3002 10 91
372075-37-1
sontuzumab
3002 10 91
705287-60-1
stamulumab
3002 10 91
339086-80-5
tadocizumab
3002 10 91
592557-43-2
(let kæde)
592557-41-0
(tung kæde)
tenatumomab
3002 10 91
876387-05-2
teplizumab
3002 10 91
918127-53-4
tigatuzumab
3002 10 91
745013-59-6
tremelimumab
3002 10 91
339986-90-2
tucotuzumabcelmoleukin
3002 10 91
728917-18-8
veltuzumab
3002 10 91
896731-82-1
conatumumab
3002 10 91
892553-42-3
etaracizumab
3002 10 91
944548-38-3
foravirumab
3002 10 91
944548-37-2
rafivirumab
3002 10 91
880266-57-9
tanezumab
3002 10 91
815610-63-0
ustekinumab
3002 10 95
862111-32-8
aflibercept
3002 10 95
845264-92-8
atacicept
3002 10 95
909110-25-4
baminercept
3002 10 95
9001-27-8
beroctocog alfa
3002 10 95
879555-13-2
epoetin kappa
3002 10 95
762263-14-9
epoetin theta
3002 10 95
501081-76-1
rilonacept
3002 10 95
267639-76-9
romiplostim
3002 10 95
869858-13-9
thrombin alfa
3002 10 95
897936-89-9
vatreptacog alfa (aktiveret)
3002 10 95
472960-22-8
albinterferon alfa-2b
3002 10 95
869881-54-9
briobacept
3002 10 95
606138-08-3
catridecacog
3002 10 95
716840-32-3
denenicokin
3002 10 95
931101-84-7
troplasminogen alfa
3002 10 99
934216-54-3
alacizumabpegol
3002 20 00
181477-43-0
disomotid
3002 20 00
181477-91-8
ovemotid
3002 20 00
915019-08-8
tertomotid
3002 20 00
295371-00-5
verpasepcaltespen
3002 90 90
473553-86-5
alferminogentadenovec
3002 90 90
929881-05-0
alipogentiparvovec
3002 90 90
600735-73-7
contusugenladenovec
3002 90 90
851199-59-2
linaclotid
3002 90 90
898830-54-1
sitimagenceradenovec
3002 90 90
721946-42-5
transferrinaldifitox
3507 90 90
9026-00-0
bucelipase alfa
3507 90 90
885051-90-1
pegloticase
3507 90 90
884604-91-5
velaglucerase alfa
3911 90 99
892497-01-7
azoximerbromid
BILAG II
Liste over præfikser og suffikser, som i forbindelse med de i bilag 3 til bilag I til forordning (EØF) nr. 2658/87 nævnte INN beskriver salte, estere eller hydrater af INN; disse salte, estere og hydrater er fritaget for told, forudsat at de kan tariferes i samme 6-cifrede HS-underposition som det tilsvarende INN
Henvisningerne til »International Nonproprietary Names (INN) for pharmaceutical substances, names for radicals and groups, comprehensive list 2004« erstattes af henvisninger til »International Nonproprietary Names (INN) for pharmaceutical substances, names for radicals, groups and others, comprehensive list 2007«.
Følgende præfikser eller suffikser tilføjes til listen i bilag 4 til bilag I til forordning (EØF) nr. 2658/87:
Foretrukket præfiks eller suffiks
Synonymer
Systematisk navn (i tilfælde af forskel)
alanetil (INNRG)
[(S)-1-ethoxy-1-oxo-propan-2-yl]amino (INNCN)
alaninat (INNRG)
L-alaninat (INNCN)
alapivoxil (INNRG)
L-alanyl, [(2,2-dimethylpropanoyl)oxy]methyl (INNCN)
aldifitox (INNRG)
(4-iminobutan-1,4-diyl)sulfandiyl[(3RS)-2,5-dioxopyrrolidin-1,3-diyl]-1,3-phenylencarbonyl, som danner et N-benzoylderivat med en gruppe af primære aminer af difteri-[550-L-phenylalanin]toksin fra 
Corynebacterium diphtheriae
-(26-560)-peptid (INNCN)
besudotox (INNRG)
L-lysyl-L-alanyl-L-serylglycylglycin (linker) fusionsprotein med des-(365-380)-[Asn
364
,Val
407
,Ser
515
,Gln
590
, Gln
606
,Arg
613
]exotoksin A (
Pseudomonas aeruginosa
)-(251-613)-peptid (toksin, hvor region IA og de første 16 rester af region IB er deleteret) (INNCN)
ceribat (INNRG)
rac-2,3-dihydroxypropylcarbonat (ester) (INNCN)
cipecilat (INNRG)
cyclohexancarboxylat (ester), cyclopropancarboxylat (ester) (INNCN)
dalanated (INNRG)
des-B30-alanin (INNCN)
enacarbil (INNRG)
{rac-1-[(2-methylpropanoyl)oxy]ethoxy}carbonyl (INNCN)
estafenatox (INNRG)
glycylglycyl-L-prolin (linker) fusionsprotein med enterotoksin type A (
Staphylococcus aureus
)-(1-33)-peptidyl-L-seryl[Ser
36
,Ser
37
,Glu
38
,Lys
39
,Ala
41
,Thr
46
,Thr
71
,Ala
72
,Ser
75
,Glu
76
,Glu
78
,Ser
80
,Ser
81
,Thr
214
,Ser
217
,Thr
219
,Ser
220
,Ser
222
, Ser
224
]enterotoksin type E (
Staphylococcus aureus
)-(32-230)-peptid (syntetisk superantigen SEA/E-120) (INNCN)
etexilat (INNRG)
ethyl, (hexyloxy)carbonyl
fosamil (INNRG)
phosphono (INNCN)
glucuronid (INNRG)
β-D-glucopyranosiduronsyre [osid] (INNCN)
medocaril (INNRG)
[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl (INNCN)
paptox (INNRG)
protein PAP (
Phytolacca americana
 antiviral) (INNCN)
placarbil (INNRG)
(R)-2-methyl-1-[(2-methylpropanoyl)oxy]propoxy}carbonyl) (INNCN)
De systematiske navne af følgende præfikser eller suffikser ændres således:
Foretrukket præfiks eller suffiks
Synonymer
Systematisk navn (i tilfælde af forskel)
aritox (INNRG)
ricins A-kæde (INNCN)
BILAG III
Liste over farmaceutiske mellemstoffer, dvs. stoffer der bruges til fremstilling af farmaceutiske færdigvarer, der skal tilføjes til listen over produkter, der er fritaget for told, i bilag 6 til bilag I til forordning (EØF) nr. 2658/87
KN-kode
CAS RN
Betegnelse
2843 29 00
22199-08-2
[4-amino-N-(pyrimidin-2(1H)-yliden-κN1)benzensulfonamidato-κO]sølv
2905 39 95
281214-27-5
(2R,3R)-2,3-dimethylbutan-1,4-diylbis(4-methylbenzensulfonat)
2905 59 98
441002-17-1
4-chlorbutyl-2-nitrobenzensulfonat
2909 30 90
92878-95-0
2-(3-chlorpropoxy)-1-methoxy-4-nitrobenzen
2909 30
503070-57-3
2-({2-[(6-bromhexyl)oxy]ethoxy}methyl)-1,3-dichlorbenzen
2909 30
461432-23-5
4-(5-brom-2-chlorbenzyl)phenylethylether
2909 49 80
185954-75-0
(3R)-3-methoxydecan-1-ol
2909 49 80
85309-91-7
2-[(2,6-dichlorbenzyl)oxy]ethanol
2909 49 80
160969-03-9
2-[2-(2,2,2-trifluorethoxy)phenoxy]ethylmethansulfonat
2909 50 00
167145-13-3
2-[2-(3-methoxyphenyl)ethyl]phenol
2910 20 00
15448-47-2
(2R)-2-methyloxiran
2910 90 00
62600-71-9
(2R)-2-(3-chlorphenyl)oxiran
2910 90 00
702687-42-1
(2R)-2-[(5-brom-2,3-difluorphenoxy)methyl]oxiran
2910 90 00
683276-64-4
[(2R)-2-methyloxiran-2-yl]methyl 4-nitrobenzensulfonat
2913 00 00
90035-34-0
4′-(trifluormethyl)biphenyl-4-carbaldehyd
2914 40 90
17752-16-8
(3β)-3-hydroxycholest-5-en-24-on
2914 50 00
974-23-2
(3β,16α)-3-hydroxy-16,17-epoxypregn-5-en-20-on
2914 70 00
13054-81-4
4-chlor-heptan-3,5-dion
2914 70 00
10226-30-9
6-chlorhexan-2-on
2915 60 90
53064-79-2
iodmethylpivalat
2915 90 00
22328-90-1
(3R)-3-methylhexansyre
2915 90 00
1069-66-5
natrium-2-propylpentanoat
2916 20 00
211515-46-7
1-(2-ethylbutyl)cyclohexancarbonylchlorid
2916 20 00
381209-09-2
1-(2-ethylbutyl)cyclohexancarboxylsyre
2916 20 00
7077-05-6
trans-4-(propan-2-yl)cyclohexancarboxylsyre
2916 39 00
21900-39-0
5-fluor-2-methylbenzoylchlorid
2916 39 00
17625-03-5
natriumhydrogen-3-sulfonatobenzoat
2917 19 90
76-72-2
diethylethyl(pentan-2-yl)propandioat
2918 29 00
376592-58-4
5′-chlor-2′-hydroxy-3′-nitrobiphenyl-3-carboxylsyre
2918 99 90
709031-28-7
(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)(oxo)eddikesyre
2918 99 90
35480-52-5
2,5-bis(2,2,2-trifluorethoxy)benzoesyre
2918 99 90
4651-67-6
(3α,5β)-3-hydroxy-7-oxocholan-24-syre
2918 99 90
52179-28-9
ethyl-2-[4-(2,2-dichlorcyclopropyl)phenoxy]-2-methylpropanoat
2918 99 90
530141-60-7
methyl-3-(5-{[4-(cyclopentyloxy)-2-hydroxyphenyl]carbonyl}-2-hydroxyphenyl)propanoat
2920 90 10
91526-18-0
4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-on
2921 49 00
334477-60-0
(1R)-1-[3,5-bis(trifluormethyl)phenyl]-N-methylethanamin
2921 49 00
376608-71-8
(1R,2S)-2-(3,4-difluorphenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoat
2921 49 00
1034457-07-2
2-(2,3-dihydro-1H-inden-2-yl)propan-2-aminhydrochlorid
2921 49 00
945717-05-5
2-(4-chlor-3-ethylphenyl)ethanaminhydrochlorid
2921 49 00
89-97-4
2-chlorbenzylamin
2921 49 00
945717-43-1
N-(4-tert-butylbenzyl)-2-(4-chlor-3-ethylphenyl)ethanamin
2921 51 90
150812-21-8
N4-[(4-fluorphenyl)methyl]-2-nitro-1,4-benzendiamin
2922 19 85
1035455-90-3
(2R)-1-(5-brom-2,3-difluorphenoxy)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}propan-2-ol hydrochlorid
2922 19 85
0-00-0
[2-(chlormethyl)-4-(dibenzylamino)phenyl]methanolhydrochlorid
2922 19 85
133-51-7
antimonsyre – 1-deoxy-1-(methylamino)-D-glucitol (1:1)
2922 19 85
1035455-87-8
ethyl-(2E)-3-(3-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}-4,5-difluorphenyl)prop-2-enoathydrochlorid
2922 19 85
702686-97-3
ethyl-3-(3-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}-4,5-difluorphenyl)propanoathydrochlorid
2922 29 00
20059-73-8
2-[4-(aminomethyl)phenoxy]-N,N-dimethylethanamin
2922 49 85
848133-35-7
(2E)-4-(dimethylamino)but-2-ensyrehydrochlorid
2922 49 85
610300-07-7
(3S,5R)-3-amino-5-methyloctansyre
2922 49 85
610300-00-0
(3S,5R)-3-amino-5-methyloctansyrehydrochlorid
2922 49 85
143785-86-8
4-(1-aminocyclopropyl)-2,3,5-trifluorbenzoesyre
2922 49 85
848949-85-9
4-fluor-L-leucin – ethylhydrogensulfat (1:1)
2922 49 85
39068-93-4
methyl-2-(dimethylamino)-2-phenylbutanoat
2922 49 85
168619-25-8
methyl-3′-aminobiphenyl-3-carboxylat
2922 49 85
82834-12-6
N-[(2S)-1-ethoxy-1-oxopentan-2-yl]-L-alanin
2922 49 85
94133-84-3
natirum-2-amino-2-phenylbutanoat
2922 50 00
503070-58-4
triphenyleddikesyre – 4-{(1R)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol (1:1)
2924 19 00
62009-47-6
2-aminomalonamid
2924 19 00
7355-58-0
N-(2-chlorethyl)acetamid
2924 29 98
361442-00-4
{2-[(tert-butoxycarbonyl)amino]-3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl}eddikesyre
2924 29 98
266993-72-0
2,3-diaminobenzamiddihydrochlorid
2924 29 98
168080-49-7
2-chlor-4-{[(5-fluor-2-methylphenyl)carbonyl]amino}benzoesyre
2924 29 98
317374-08-6
2-methyl-4-{[(2-methylphenyl)carbonyl]amino}benzoesyre
2924 29 98
143785-84-6
4-(1-carbamoylcyclopropyl)-2,3,5-trifluorbenzoesyre
2924 29 98
143785-87-9
4-[1-(acetylamino)cyclopropyl]-2,3,5-trifluorbenzoesyre
2924 29 98
108166-22-9
4-{[(2-methylphenyl)carbonyl]amino}benzoesyre
2924 29 98
150812-23-0
ethyl-{4-[(4-fluorbenzyl)amino]-2-nitrophenyl}carbamat
2924 29 98
22316-45-6
ethyl-3-[(5-chlor-2-nitrophenyl)(phenyl)amino]-3-oxopropanoat
2924 29 98
316173-29-2
methyl-(1S,2S,3S,4R)-3-[(1S)-1-amino-2-ethylbutyl]-4-[(tert-butoxycarbonyl)amino]-2-hydroxycyclopentancarboxylat
2924 29 98
1142-20-7
N-benzyloxycarbonyl-L-alanin
2924 29 98
84996-93-0
N-cyclohexyl-5-hydroxypentanamid
2924 29 98
579494-66-9
propyl-{4-[2-(diethylamino)-2-oxoethoxy]-3-ethoxyphenyl}acetat
2925 19 95
265136-65-0
ethyl-3-amino-4-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]but-2-enoat
2926 90 95
855425-38-6
1-(2-ethylbutyl)cyclohexancarbonitril
2926 90 95
846023-24-3
2-cyan-N-(2,4-dichlor-5-methoxyphenyl)acetamid
2926 90 95
591769-05-0
3-cyclopentylprop-2-enenitril
2926 90 95
20099-89-2
4-(bromacetyl)benzonitril
2926 90 95
474554-45-5
4,5-diethoxy-3-fluorbenzen-1,2-dicarbonitril
2926 90 95
79370-78-8
5-hydroxybenzen-1,3-dicarbonitril
2926 90 95
139481-28-0
methyl-2-{[(2′-cyanbiphenyl-4-yl)methyl]amino}-3-nitrobenzoat
2928 00 90
860035-10-5
1-({[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl}oxy)ethyl-2-methylpropanoat
2928 00 90
910656-45-0
2-hydroxy-2-(trifluormethyl)butanhydrazid
2928 00 90
95759-10-7
4-chlor-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutansyre
2928 00 90
473927-63-8
ethyl-(2Z)-chlor[2-(4-methoxyphenyl)hydrazinyliden]ethanoat
2928 00 90
158671-29-5
N,2-dihydroxy-4-methylbenzamid
2928 00 90
84080-68-2
tert-butyl-(2Z)-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoat
2928 00 90
268544-50-9
tert-butyl-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoat
2930 90 99
13459-62-6
{2-[(4-chlorphenyl)sulfanyl]phenyl}eddikesyre
2930 90 99
211513-21-2
1-(2-ethylbutyl)-N-(2-sulfanylphenyl)cyclohexancarboxamid
2930 90 99
860035-07-0
1-{[(methylsulfanyl)carbonyl]oxy}ethyl-2-methylpropanoat
2930 90 99
893407-18-6
2,2,2-trifluor-1-[4′-(methylsulfonyl)biphenyl-4-yl]ethanon
2930 90 99
60759-00-4
3,4-diethoxybenzencarbothioamid
2930 90 99
21048-05-5
N-methylbenzencarbothiohydrazid
2931 00 99
13682-94-5
(2-bromethenyl)(trimethyl)silan
2931 00 99
914922-89-7
(2R,4R)-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-N-methoxy-N,2-dimethyl-7-oxoheptanamid
2931 00 99
914922-88-6
(2R,4R)-4-{[tert-butyl(dimethyl)silyl]oxy}-N-methoxy-N,2-dimethyloct-7-enamid
2931 00 99
871355-80-5
(4R)-2-brom-7-{[tert-butyl(diphenyl)silyl]oxy}hept-1-en-4-yl 4-methylbenzensulfonat
2931 00 99
89694-48-4
(5-chlor-2-methoxyphenyl)boronsyre
2931 00 99
701278-08-2
[(1R,5S)-5-[dimethyl(phenyl)silyl]-2-{[(2-methoxypropan-2-yl)oxy]methyl}cyclopent-2-en-1-yl]methanol
2931 00 99
701278-09-3
{(4S,5R)-5-[(benzyloxy)methyl]-4-[dimethyl(phenyl)silyl]cyclopent-1-en-1-yl}methanol
2931 00 99
796967-18-5
1-(2-fluor-5-methylphenyl)-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea
2931 00 99
172732-52-4
2-(1,3,2-dioxaborinan-2-yl)benzonitril
2931 00 99
185411-12-5
methyl-3-(trimethylsilyl)pent-4-enoat
2932 19 00
253128-10-8
(1S)-1,5:7,10-dianhydro-12,13-bis-O-[tert-butyl(dimethyl)silyl]-2,3,4,6,8,11-hexadeoxy-1-{2-[(2S,5S)-5-(3-hydroxypropyl)-3-methylidentetrahydrofuran-2-yl]ethyl}-3-methyl-9-O-methyl-4-methyliden-8-[(phenylsulfonyl)methyl]-D-arabino-D-altro-tridecitol
2932 19 00
441045-17-6
(1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-bis(methylen)-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-on-methansulfonat
2932 29 85
916069-80-2
(4S)-4-(fluormethyl)dihydrofuran-2(3H)-on
2932 29 85
63106-93-4
1-phenyl-3-oxabicyclo[3.1.0]hexan-2-on
2932 29 85
7734-80-7
2-oxo-2H-chromen-6-carboxylsyre
2932 29 85
0-00-0
4-(4-fluorphenyl)-7-(isothiocyanatomethyl)-2H-chromen-2-on
2932 29 85
947408-91-5
6-[(2,4-dihydroxyphenyl)carbonyl]-2H-chromen-2-on
2932 29 85
947408-90-4
6-[(2,4-dimethoxyphenyl)carbonyl]-2H-chromen-2-on
2932 99 00
452342-08-4
(1R)-2-(benzylamino)-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)ethanol
2932 99 00
99541-23-8
(1R,2S,3R,4R,5R)-4-azido-2-{[(4aR,6S,7R,8S,8aR)-7,8-bis(benzyloxy)-2-phenylhexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy}-6,8-dioxabicyclo[3.2.1]oct-3-yl acetat
2932 99 00
461432-25-7
(1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-[4-chlor-3-(4-ethoxybenzyl)phenyl]-D-glucitol
2932 99 00
196597-79-2
(2E)-1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylidenethannitril
2932 99 00
3308-94-9
2-(3-chlorpropyl)-2-(4-fluorphenyl)-1,3-dioxolan
2932 99 00
274693-53-7
[(3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]carbamat
2932 99 00
185954-98-7
[6(2Z,3R)]-3-O-decyl-2-deoxy-6-O-[2-deoxy-3-O-(3-metoxydecyl)-6-methyl-2-[(1-oxo-11-octadecenyl)amino]-4-O-phosphono-β-D-glucopyranosyl]-2-[(1,3-dioxotetradecyl)amino]-α-D-glucopyranose-1-(dihydrogenphosphat)tetranatriumsalt
2932 99 00
136172-58-2
1,6-di-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-D-glucopyranose
2932 99 00
196597-80-5
2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethanaminhydrochlorid
2932 99 00
666860-59-9
2-amino-2-oxoethyl{3-[trans-5-(6-methoxynaphthalen-1-yl)-1,3-dioxan-2-yl]propyl}carbamat
2932 99 00
117661-72-0
5-(chlormethyl)-6-methyl-1,3-benzodioxol
2932 99 00
959624-24-9
6-(hydroxymethyl)-4-phenyl-3,4-dihydro-2H-chromen-2-ol
2932 99 00
960404-59-5
but-2-yn-1,4-diol – methyl 1-C-[4-chlor-3-(4-ethoxybenzyl)phenyl]-α-D-glucopyranosid (1:1)
2932 99 00
15826-37-6
dinatrium-5,5′-[(2-hydroxypropan-1,3-diyl)bis(oxy)]bis(4-oxo-4H-chromen-2-carboxylat)
2932 99 00
204254-84-2
ethyl-(3aR,7R,7aR)-2,2-dimethyl-7-[(methylsulfonyl)oxy]-3a,6,7,7a-tetrahydro-1,3-benzodioxol-5-carboxylat
2932 99 00
99541-26-1
methyl-(2S,3S,4S,5S,6S)-6-{[(1S,2S,3S,4R,5R)-3-(acetyloxy)-4-azido-6,8-dioxabicyclo[3.2.1]oct-2-yl]methyl}-4,5-bis(benzyloxy)-3-hydroxytetrahydro-2H-pyran-2-carboxylat
2932 99 00
114869-97-5
methyl-6-O-acetyl-4-O-(2-O-acetyl-3-O-benzyl-6-methyl-α-L-idopyranuronosyl)-3-O-benzyl-2-{[(benzyloxy)carbonyl]amino}-2-deoxy-α-D-glucopyranosid
2933 19 90
1035677-60-1
(4S)-3-(4-chlorphenyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazol-1-carboximidamid-2,3-dihydroxybutandioat
2933 19 90
18048-64-1
2-(3,4-dimethylphenyl)-5-methyl-2,4-dihydro-3H-pyrazol-3-on
2933 19 90
1035675-24-1
3-(4-chlorphenyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazol-1-carboximidamid
2933 19 90
1028026-83-6
5-methyl-1-(propan-2-yl)-4-[4-(propan-2-yloxy)benzyl]-1,2-dihydro-3H-pyrazol-3-on
2933 19 90
473921-12-9
5-{[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy}benzen-1,3-dicarbonitril
2933 29 90
65902-59-2
2-brom-4-nitro-1H-imidazol
2933 29 90
57531-37-0
2-chlor-4-nitro-1H-imidazol
2933 29 90
1000164-35-1
3-(1,1-dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-1-(triphenylmethyl)-L-histidyl-2-methylalanyl-L-α-glutamylglycin
2933 29 90
152074-97-0
L-α-aspartyl-L-α-glutamyl-L-asparaginyl-L-prolyl-L-valyl-L-valyl-L-histidyl-L-phenylalanyl-L-phenylalanyl-L-lysyl-L-asparaginyl-L-isoleucyl-L-valyl-L-threonyl-L-prolyl-L-arginyl-L-threonin
2933 29 90
781666-30-6
L-α-aspartyl-L-α-glutamyl-L-asparaginyl-L-prolyl-L-valyl-L-valyl-L-histidyl-L-phenylalanyl-L-phenylalanyl-L-lysyl-L-asparaginyl-L-isoleucyl-L-valyl-L-threonyl-L-prolyl-L-arginyl-L-threonintetraacetat
2933 29 90
451470-33-0
methyl-3′-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)biphenyl-3-carboxylat
2933 39 99
925978-49-0
(+)-5-[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]-1-azabicyclo[3.2.1]octan
2933 39 99
876170-44-4
(1S,5S)-3-(5,6-dichlorpyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptanbenzensulfonat
2933 39 99
741705-70-4
(2R)-phenyl[(2R)-piperidin-2-yl]ethansyrehydrochlorid
2933 39 99
414910-13-7
(2S)-hydroxy(phenyl)ethansyre – (2R)-2-(4-fluor-2-methylphenyl)piperidin-4-on (1:1)
2933 39 99
0-00-0
(3aR,6aR)-1-(pyridin-3-yl)octahydropyrrolo[3,4-b]pyrrol-4-methylbenzensulfonat
2933 39 99
370882-57-8
(3aR,6aR)-1-(pyridin-3-yl)octahydropyrrolo[3,4-b]pyrroldihydrochlorid
2933 39 99
334618-23-4
(3R)-piperidin-3-amindihydrochlorid
2933 39 99
1062580-52-2
(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amindihydrochlorid
2933 39 99
27262-47-1
(S)-1-butyl-N-(2,6-dimethylphenyl)piperidin-2-carboxamid
2933 39 99
105812-81-5
[(3S,4R)-4-(4-fluorphenyl)-1-methylpiperidin-3-yl]methanol
2933 39 99
876068-51-8
[(3S,4S)-4-amino-1-(5,6-dichlorpyridin-3-yl)pyrrolidin-3-yl]methanol
2933 39 99
871022-14-9
1-({4-[({[2-oxo-3-(propan-2-yl)-2,3-dihydro-1H-benzimidazol-1-yl]carbonyl}amino)methyl]piperidin-1-yl}methyl)cyclobutancarboxylsyre
2933 39 99
5421-92-1
1-(pyridin-4-yl)pyridiniumchloridhydrochlorid
2933 39 99
272776-12-2
1,1′-binaphthalen-2,2′-diol – 5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazol (1:1)
2933 39 99
871022-19-4
1-[(4-{[(tert-butoxycarbonyl)amino]methyl}piperidin-1-yl)methyl]cyclobutancarboxylsyre
2933 39 99
3613-73-8
2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol
2933 39 99
179687-79-7
2-[(2-chlor-4-nitrophenoxy)methyl]pyridin
2933 39 99
122321-04-4
2-[methyl(pyridin-2-yl)amino]ethanol
2933 39 99
945405-37-8
2-methyl-3-[(2S)-pyrrolidin-2-ylmethoxy]pyridin-2,3-dihydroxybutandioat
2933 39 99
936637-40-0
3,3′-piperidin-1,4-diyldipropan-1-ol 4-methylbenzensulfonat
2933 39 99
88150-62-3
3-ethyl-5-methyl-4-(2-chlorphenyl)-2-{[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]methyl}-6-methyl-1,4-dihydropyridin-3,5-dicarboxylat
2933 39 99
84100-54-9
4-(ethylamino)piperidin-4-carboxamid
2933 39 99
873546-30-6
4,4′-[piperidin-1,4-diylbis(propan-3,1-diyloxy)]bis(N′-hydroxybenzencarboximidamid)
2933 39 99
873546-74-8
4,4′-[piperidin-1,4-diylbis(propan-3,1-diyloxy)]bis[N′-(acetyloxy)benzencarboximidamid]
2933 39 99
873546-38-4
4,4′-[piperidin-1,4-diylbis(propan-3,1-diyloxy)]dibenzencarboximidamidtrihydrochloridpentahydrat
2933 39 99
873546-80-6
4,4′-[piperidin-1,4-diylbis(propan-3,1-diyloxy)]dibenzonitril
2933 39 99
78750-61-5
4-[(3-nitropyridin-2-yl)amino]phenol
2933 39 99
866109-93-5
4-{4-[4-(trifluormethoxy)phenoxy]piperidin-1-yl}phenol 4-methylbenzensulfonat
2933 39 99
927889-51-8
4-brom-2,6-diethylpyridin-4-methylbenzensulfonat
2933 39 99
691882-47-0
4-hydroxybenzoesyre – (2S,4E)-N-methyl-5-[5-(propan-2-yloxy)pyridin-3-yl]pent-4-en-2-amin (1:1)
2933 39 99
876068-46-1
5,6-dichlor-N-(2,2-dimethoxyethyl)pyridin-3-amin
2933 39 99
1072-98-6
5-chlorpyridin-2-amin
2933 39 99
298692-34-9
6-(chloracetyl)pyridin-2-carboxylsyre
2933 39 99
550349-58-1
7-chlor-3-(6-methoxypyridin-3-yl)-N,N,5-trimethyl-4-oxo-4,5-dihydro-3H-pyridazino[4,5-b]indol-1-carboxamid
2933 39 99
414909-98-1
benzyl 2-(4-fluor-2-methylphenyl)-4-oxo-3,4-dihydropyridin-1(2H)-carboxylat
2933 39 99
56880-11-6
ethyl-[(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl)acetat
2933 39 99
548797-97-3
N-(2-{[(2S)-3-{[1-(4-chlorbenzyl)piperidin-4-yl]amino}-2-hydroxy-2-methylpropyl]oxy}-4-hydroxyphenyl)acetamid
2933 39 99
0-00-0
N-[(S)-1-azabicyclo[2.2.2]oct-2-yl(phenyl)methyl]-2,6-dichlor-3-(trifluormethyl)benzamidhydrochlorid
2933 39 99
329003-65-8
natriumhydrogen[1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonathemipentahydrat
2933 49 10
417716-92-8
4-{3-chlor-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinolin-6-carboxamidmethansulfonat
2933 49 90
503291-53-0
2-ethylbutyl (3S,4aS,6S,8aR)-6-[3-chlor-2-(1H-tetrazol-5-yl)phenoxy]decahydro-3-isoquinolincarboxylat 4-methylbenzensulfonat
2933 49 90
103733-32-0
benzyl-(3S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-3-carboxylathydrochlorid
2933 49 90
503293-98-9
(3S,4aS,6S,8aR)-6-hydroxy-2-(methoxycarbonyl)decahydroisoquinolin-3-carboxylsyre
2933 49 90
503290-66-2
(3S,4aS,6S,8aR)-6-[3-chlor-2-(2H-tetrazol-5-yl)phenoxy]decahydro-3-isoquinolincarboxylisyrehydrochlorid
2933 49 90
134388-95-7
(3S,4aS,8aR)-2-(methoxycarbonyl)-6-oxodecahydroisoquinolin-3-carboxylsyre – (1R)-1-phenylethanamin (1:1)
2933 49 90
868210-14-4
4-(4-{[(2S,4R)-4-[acetyl(4-chlorphenyl)amino]-2-methyl-3,4-dihydroquinolin-1(2H)-yl]carbonyl}phenoxy)-2,2-dimethylbutansyre
2933 49 90
00-00-0
methyl 2-[(3R)-3-{3-[(E)-2-(7-chlorquinolin-2-yl)ethenyl]phenyl}-3-({[1-(hydroxymethyl)cyclopropyl]methyl}sulfanyl)propyl]benzoathydrochlorid
2933 49 90
848133-76-6
N-(4-chlor-3-cyan-7-ethoxyquinolin-6-yl)acetamid
2933 59 95
869490-23-3
(3,3-difluorpyrrolidin-1-yl){(2S,4S)-4-[4-(pyrimidin-2-yl)piperazin-1-yl]pyrrolidin-2-yl}methanon
2933 59 95
941685-40-1
(3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propannitril
2933 59 95
941678-49-5
(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propannitril
2933 59 95
941685-41-2
(3S)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propannitril
2933 59 95
957187-34-7
[(8R)-8-(3,5-difluorphenyl)-10-oxo-6,9-diazaspiro[4.5]dec-9-yl]eddikesyre
2933 59 95
356058-42-9
{2-[(4-fluorbenzyl)sulfanyl]-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl}eddikesyre
2933 59 95
0-00-0
2,3-dihydroxy-2,3-bis(phenylcarbonyl)butandisyre – ethyl-[(8R)-8-(3,5-difluorphenyl)-10-oxo-6,9-diazaspiro[4.5]dec-9-yl]acetat (1:1)
2933 59 95
90213-66-4
2,4-dichlor-7H-pyrrolo[2,3-d]pyrimidin
2933 59 95
3934-20-1
2,4-dichlorpyrimidin
2933 59 95
451487-18-6
2-[(4-fluorbenzyl)sulfanyl]-1,5,6,7-tetrahydro-4H-cyclopenta[d]pyrimidin-4-on
2933 59 95
865758-96-9
2-[(6-chlor-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]benzonitril
2933 59 95
934815-71-1
2-[3-(6-{[2-(2,4-dichlorphenyl)ethyl]amino}-2-methoxypyrimidin-4-yl)phenyl]-2-methylpropansyrephosphat
2933 59 95
722543-31-9
2-{ethyl[3-({4-[(5-{2-[(3-fluorphenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]quinazolin-7-yl}oxy)propyl]amino}ethyldihydrogenphosphat
2933 59 95
1032066-96-8
2-amino-9-{(1S,3R,4S)-3-[(benzyloxy)methyl]-4-[dimethyl(phenyl)silyl]-2-methylidencyclopentyl}-1,9-dihydro-6H-purin-6-on – methansulfonat (2:1)
2933 59 95
540737-29-9
3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropannitril-2-hydroxypropan-1,2,3-tricarboxylat
2933 59 95
1137917-12-4
3-{[6-(ethylsulfonyl)pyridin-3-yl]oxy}-5-{[(2S)-1-hydroxypropan-2-yl]oxy}benzoesyre – 1,4-diazabicyclo[2.2.2]octan (2:1)
2933 59 95
941685-39-8
3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propannitril
2933 59 95
941685-27-4
4-(1H-pyrazol-4-yl)-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin
2933 59 95
1780-26-3
4,6-dichlor-2-methylpyrimidin
2933 59 95
145783-14-8
4,6-dichlor-5-nitro-2-(propylsulfanyl)pyrimidin
2933 59 95
3680-69-1
4-chlor-7H-pyrrolo[2,3-d]pyrimidin
2933 59 95
61379-64-4
4-cyclopentylpiperazin-1-amin
2933 59 95
55112-42-0
4-methylpiperazin-1-carbonylchloridhydrochlorid
2933 59 95
0-00-0
5-(benzylamino)-2-(3-methoxyphenyl)-7-(4-methylpiperazin-1-yl)[1,2,4]triazolo[1,5-a]quinolin-4-carbonitril – (2E)-but-2-endioat (2:1) hydrat
2933 59 95
55293-96-4
5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-carbaldehyd
2933 59 95
179688-01-8
7-(benzyloxy)-6-methoxyquinazolin-4(3H)-on
2933 59 95
444731-74-2
N-(2-chlorpyrimidin-4-yl)-2,3-dimethyl-2H-indazol-6-amin
2933 59 95
0-00-0
N-(5-fluor-3-methyl-1H-indol-1-yl)-4-methyl-2-(pyridin-2-yl)pyrimidin-5-carboxamid
2933 79 00
586414-48-4
(-)-3-{3-brom-4-[(2,4-difluorbenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl}-N,4-dimethylbenzamid
2933 79 00
425663-71-4
(1S)-1-amino-3-methyl-1,3,4,5-tetrahydro-2H-3-benzazepin-2-on-hydrochlorid
2933 79 00
813452-14-1
(4S)-1-[(2S,3S,11bS)-2-amino-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-3-yl]-4-(fluormethyl)pyrrolidin-2-on-dihydrochlorid
2933 79 00
5162-90-3
3-(2-oxo-1,2-dihydroquinolin-4-yl)alanin
2933 79 00
536760-29-9
3-chlor-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-on
2933 79 00
4876-10-2
4-(brommethyl)quinolin-2(1H)-on
2933 79 00
5057-12-5
4,6,7,8-tetrahydroquinolin-2,5(1H,3H)-dion
2933 79 00
54197-66-9
6-hydroxy-3,4-dihydroquinolin-2(1H)-on
2933 79 00
22246-18-0
7-hydroxy-3,4-dihydroquinolin-2(1H)-on
2933 79 00
536759-91-8
ethyl-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-3-carboxylat
2933 79 00
503614-91-3
ethyl-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-3-carboxylat
2933 79 00
586379-61-5
methyl-3-(4-hydroxy-6-methyl-2-oxopyridin-1(2H)-yl)-4-methylbenzoat
2933 99 80
709031-45-8
(1S,3S,5S)-2-azabicyclo[3.1.0]hexan-3-carboxamidmethansulfonat
2933 99 80
649735-46-6
(2R)-1-({4-[(4-fluor-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl}oxy)propan-2-ol
2933 99 80
51077-14-6
(2S)-1-(tert-butoxycarbonyl)azetidin-2-carboxylsyre
2933 99 80
631916-97-7
(2S)-N-{4-[(Z)-amino(methoxyimino)methyl]benzyl}-1-{(2R)-2-[3-chlor-5-(difluormethoxy)phenyl]-2-hydroxyethanoyl}azetidin-2-carboxamid – benzensulfonsyre (1:1)
2933 99 80
80875-98-5
(2S,3aS,7aS)-octahydro-1H-indol-2-carboxylsyre
2933 99 80
948846-40-0
(2S,3S)-2,3-bis[(phenylcarbonyl)oxy]butandisyre – ethyl-(3aR,6aR)-hexahydropyrrolo[3,4-b]pyrrol-5(1H)-carboxylat (1:1)
2933 99 80
1000164-36-2
(5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S)-5-(3-amino-3-oxopropyl)-20-benzyl-23-[(2S)-butan-2-yl]-14,38-bis{4-[(tert-butoxycarbonyl)amino]butyl}-29-{[1-(tert-butoxycarbonyl)-1H-indol-3-yl]methyl}-17-(3-tert-butoxy-3-oxopropyl)-1-(1H-fluoren-9-yl)-8,11,26,41,41-pentamethyl-32-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-35-(propan-2-yl)-2-oxa-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecaazadotetracontan-42-syre
2933 99 80
22162-51-2
1-(2-nitrobenzyl)-1H-pyrrol-2-carbaldehyd
2933 99 80
35681-40-4
1-(propan-2-yl)-1,3-dihydro-2H-benzimidazol-2-on
2933 99 80
166170-15-6
1-(tert-butoxycarbonyl)-2-methyl-D-prolin
2933 99 80
796967-16-3
1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluor-5-methylphenyl)urea
2933 99 80
0-00-0
1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluor-5-methylphenyl)ureahydrochlorid
2933 99 80
444731-72-0
2,3-dimethyl-2H-indazol-6-amin
2933 99 80
19686-05-6
2,8-dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol
2933 99 80
912444-00-9
2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazol-4-carboxamid
2933 99 80
912445-36-4
2-[(2S)-2-methylpyrrolidin-2-yl]-1H-benzimidazol-4-carboxamiddihydrochlorid
2933 99 80
163457-23-6
3,3-difluorpyrrolidinhydrochlorid
2933 99 80
239463-85-5
3-{5-[(2R)-2-aminopropyl]-7-cyan-2,3-dihydro-1H-indol-1-yl}propylbenzoat-(2R,3R)-2,3-dihydroxybutandioat
2933 99 80
55321-99-8
3-oxo-3,4-dihydropyrazin-2-carboxamid
2933 99 80
952490-01-6
4-[(4-fluor-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl 2,2-dimethylpropanoat
2933 99 80
942436-93-3
4-amino-8-(2,5-dimethoxyphenyl)-N-propylcinnolin-3-carboxamid
2933 99 80
942437-37-8
4-amino-8-(2-fluor-6-methoxyphenyl)-N-propylcinnolin-3-carboxamid
2933 99 80
288385-88-6
4-fluor-2-methyl-1H-indol-5-ol
2933 99 80
503293-47-8
5-(2-chlor-6-fluorphenyl)-2H-tetrazol
2933 99 80
73963-42-5
5-(4-chlorbutyl)-1-cyclohexyl-1H-tetrazol
2933 99 80
606143-52-6
5-[(4-brom-2-chlorphenyl)amino]-4-fluor-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazol-6-carboxamid
2933 99 80
0-00-0
5-fluor-1-(3-fluorbenzyl)-N-(1H-indol-5-yl)-1H-indol-2-carboxamid
2933 99 80
872206-47-8
5-methyl-4-oxo-1,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl-2,2-dimethylpropanoat
2933 99 80
259793-88-9
6-brom-3-oxo-3,4-dihydropyrazin-2-carboxamid
2933 99 80
1137606-74-6
6-fluor-3-oxo-3,4-dihydropyrazin-2-carbonitril – N-cyclohexylcyclohexanamin (1:1)
2933 99 80
261953-36-0
6-iod-1H-indazol
2933 99 80
80076-47-7
8,9-difluor-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinolin-2-carboxylsyre
2933 99 80
52602-39-8
9H-carbazol-4-ol
2933 99 80
145641-35-6
benzyl-(2S,3aR,7aS)-octahydro-1H-indol-2-carboxylathydrochlorid
2933 99 80
87269-87-2
benzyl-(2S,3aS,6aS)-octahydrocyclopenta[b]pyrrol-2-carboxylathydrochlorid
2933 99 80
1012065-72-3
ethyl-2-amino-9,10-dimethoxy-1,6,7,11b-tetrahydro-4H-pyrido[2,1-a]isoquinolin-3-carboxylat
2933 99 80
131707-24-9
ethyl-6-brom-5-hydroxy-1-methyl-2-[(phenylsulfanyl)methyl]-1H-indol-3-carboxylat
2933 99 80
105152-95-2
ethyl-7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorphenyl)-6-fluor-4-oxo-1,4-dihydro-1,8-naphthyridin-3-carboxylat
2933 99 80
139481-44-0
methyl-1-[(2′-cyanbiphenyl-4-yl)methyl]-2-ethoxy-1H-benzimidazol-7-carboxylat
2933 99 80
0-00-0
methyl-1-tert-butyl-2-hydroxy-1H-pyrrolo[2,3-b]pyridin-3-carboxylat
2933 99 80
21688-11-9
N2-[(benzyloxy)carbonyl]-L-glutaminyl-L-asparaginyl-S-benzyl-L-cysteinyl-L-prolyl-L-leucylglycinamid
2933 99 80
361440-67-7
tert-butyl-(1S,3S,5S)-3-carbamoyl-2-azabicyclo[3.1.0]hexan-2-carboxylat
2933 99 80
709031-38-9
tert-butyl-(2S)-2-carbamoyl-2,3-dihydro-1H-pyrrol-1-carboxylat
2933 99 80
709031-43-6
tert-butyl-[(1S)-2-[(1S,3S,5S)-3-cyan-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)-2-oxoethyl]carbamat
2933 49 90
936359-25-0
methyl-2-((R)-3-(3-((E)-2-(7-chlorquinolin-2-yl)vinyl)phenyl)-3-(((1-(hydroxymethyl)cyclopropyl)methyl)sulfanyl)propyl)benzoat
2934 10 00
110130-88-6
(2Z)-[(acetyloxy)imino](2-amino-1,3-thiazol-4-yl)ethansyre
2934 10 00
68672-66-2
(2Z)-{[(1-tert-butoxy-2-methyl-1-oxopropan-2-yl)oxy]imino}[2-(tritylamino)-1,3-thiazol-4-yl]ethansyre
2934 10 00
291536-35-1
(5Z)-5-(4-fluorbenzyliden)-1,3-thiazolidin-2,4-dion
2934 10 00
302964-24-5
2-amino-N-(2-chlor-6-methylphenyl)-1,3-thiazol-5-carboxamid
2934 10 00
866920-24-3
3-[2-chlor-4-({4-methyl-2-[4-(trifluormethyl)phenyl]-1,3-thiazol-5-yl}methoxy)phenyl]-1,2,4-oxadiazol-5(4H)-on
2934 10 00
752253-39-7
4-(2-chlor-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluor-4-methylphenyl)ethyl]-5-methyl-N-(prop-2-yn-1-yl)-1,3-thiazol-2-amin
2934 10 00
914361-45-8
L-lysin – {[(2R,3R)-3-[4-(4-cyanphenyl)-1,3-thiazol-2-yl]-2-(2,4-difluorphenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-yl]oxy}methyldihydrogenphosphat – ethanol (1:1:1)
2934 10 00
302964-08-5
N-(2-chlor-6-methylphenyl)-2-[(6-chlor-2-methylpyrimidin-4-yl)amino]-1,3-thiazol-5-carboxamid
2934 10 00
127660-04-2
natrium-(2Z)-(2-amino-1,3-thiazol-4-yl)(hydroxyimino)ethanoat
2934 99 90
17381-54-3
(1-benzothiophen-5-yl)eddikesyre
2934 99 90
630100-90-2
(1R)-1,2-anhydro-4-C-{(1E,3E)-4-[(1S,2S,3E,5R,6R,9R)-5-(1-carboxylato-4-cycloheptylpiperazin-2-yl)-6,9-dihydroxy-2,6-dimethyl-11-oxooxacyclododec-3-en-1-yl]penta-1,3-dien-1-yl}-3,5-dideoxy-1-[(2R,3S)-3-hydroxypentan-2-yl]-D-erythropentitol
2934 99 90
220099-91-2
(2R)-3′H-spiro[4-azabicyclo[2.2.2]octan-2,2′-furo[2,3-b]pyridin]
2934 99 90
220100-81-2
(2R)-3′H-spiro[4-azabicyclo[2.2.2]octan-2,2′-furo[2,3-b]pyridin] (S,S)-2,3-dihydroxybutandioat
2934 99 90
161599-46-8
(2R,3R,4R,5R)-2-(4-amino-5-fluor-2-oxopyrimidin-1(2H)-yl)-2-fluor-5-methyltetrahydrofuran-3,4-diyldiacetat
2934 99 90
690270-65-6
(2R,3S,4R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-azido-2-{[(2-methylpropanoyl)oxy]methyl}tetrahydrofuran-3,4-diylbis(2-methylpropanoat)hydrochlorid
2934 99 90
265121-04-8
(3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluormethyl)phenyl]ethoxy}-3-(2-fluorphenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonsyre – 1-deoxy-1-(methylamino)-D-glucitol (1:2)
2934 99 90
163680-80-6
(3S)-10-[1-(acetylamino)cyclopropyl]-9-fluor-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-6-carboxylsyre
2934 99 90
132335-46-7
(3S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amin
2934 99 90
133413-70-4
(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-4,10,12,16,22,24-hexamethyl-3,9,15,21-tetrakis(2-methylpropyl)-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclotetracosan-2,5,8,11,14,17,20,23-octon
2934 99 90
503068-36-8
(5R)-3-(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-on
2934 99 90
452339-73-0
(5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-on
2934 99 90
877130-28-4
(6R)-6-cyclopentyl-6-[2-(2,6-diethylpyridin-4-yl)ethyl]-3-[(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl]-4-hydroxy-5,6-dihydro-2H-pyran-2-on
2934 99 90
132335-44-5
(S)-3-(dimethylamino)-1-(thiophen-2-yl)propan-1-ol
2934 99 90
812647-80-6
{(2R,3S,4R,5R)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-bis[(phenylcarbonyl)oxy]tetrahydrofuran-2-yl}methyl 3-chlorbenzoat
2934 99 90
00-00-0
1-(1-{4-[2-(4-fluorphenyl)-1,3-dioxolan-2-yl]butyl}-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-2H-benzimidazol-2-on
2934 99 90
1029716-44-6
1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol
2934 99 90
165172-60-1
1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidin-2,4(1H,3H)-dion – 1-methylpyrrolidin-2-on (1:1)
2934 99 90
519187-97-4
1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-3-azetidinol – (2Z)-2-butendioat (1:1)
2934 99 90
127000-90-2
1-{[(2R,3S)-2-(2,4-difluorphenyl)-3-methyloxiran-2-yl]methyl}-1H-1,2,4-triazol
2934 99 90
710281-33-7
2-({[(1R,3S)-3-{[2-(3-methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methoxy}cyclohexyl]oxy}methyl)-6-methylbenzoesyre
2934 99 90
96803-30-4
2-(1-benzothiophen-5-yl)ethanol
2934 99 90
913695-00-8
2-[({4-[(2,2-dimethyl-1,3-dioxan-5-yl)methoxy]-3,5-dimethylpyridin-2-yl}methyl)sulfinyl]-1H-benzimidazol, natriumsalt (1:1)
2934 99 90
376608-74-1
2-{[(3aR,4S,6R,6aS)-6-{[5-amino-6-chlor-2-(propylsulfanyl)pyrimidin-4-yl]amino}-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy}ethanol
2934 99 90
474554-48-8
2-brom-1-[3-tert-butyl-4-methoxy-5-(morpholin-4-yl)phenyl]ethanon
2934 99 90
530141-72-1
3-(5-{[4-(cyclopentyloxy)-2-hydroxyphenyl]carbonyl}-2-[(3-hydroxy-1,2-benzoxazol-6-yl)methoxy]phenyl)propansyre
2934 99 90
519188-55-7
3-[2-(1-benzothiophen-5-yl)ethoxy]-1-(3-hydroxyazetidin-1-yl)propan-1-on
2934 99 90
519188-42-2
3-[2-(1-benzothiophen-5-yl)ethoxy]propionsyre
2934 99 90
753015-42-8
3-{(E)-2-[(3R)-pyrrolidin-3-yl]ethenyl}-5-(tetrahydro-2H-pyran-4-yloxy)pyridin
2934 99 90
26638-53-9
3-chlor-6-methyldibenzo[c,f][1,2]thiazepin-11(6H)-on-5,5-dioxid
2934 99 90
499785-81-8
3-oxo-4-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-3,4-dihydropyrazin-2-carboxamid
2934 99 90
356782-84-8
3-oxo-4-(β-D-ribofuranosyl)-3,4-dihydropyrazin-2-carboxamid
2934 99 90
6504-57-0
4-[3-hydroxy-3-phenyl-3-(thiophen-2-yl)propyl]-4-methylmorpholin-4-iummethylsulfat
2934 99 90
871484-32-1
4-[4-({3-[(4-deoxy-4-fluor-b-D-glucopyranosyl)oxy]-5-(propan-2-yl)-1H-pyrazol-4-yl}methyl)phenyl]-N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]butanamid
2934 99 90
166964-09-6
4-chlor-3-methyl-1,2-oxazol-5-amin
2934 99 90
655233-39-3
4-nitrobenzyl(6R,7R)-7-amino-8-oxo-3-[(2S)-tetrahydrofuran-2-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carboxylathydrochlorid
2920 90 85
89729-09-9
5,7-dioxa-6-thiaspiro[2.5]octan-6-oxid
2934 99 90
388082-75-5
5-[4-[[3-chlor-4-[(3-fluorphenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furancarboxaldehyd – 4-methylbenzensulfonat (1:1)
2934 99 90
4923-87-9
5-brom-1-benzothiophen
2934 99 90
947408-95-9
6-(brommethyl)-2-triphenylmethyl-1,2-benzisoxazol-3(2H)-on
2934 99 90
947408-94-8
6-methyl-2-trityl-1,2-benzoxazol-3(2H)-on
2934 99 90
67978-05-6
diphenylmethyl(2R)-3-methyl-2-[(1R,5S)-3-(4-methylphenyl)-7-oxo-4-oxa-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl]but-3-enoat
2934 99 90
1001859-46-6
DNA (syntetisk plasmidvektor pCOR, som udtrykker et fusionsprotein af humant interferon beta signalpeptid og 21-154 af human sur fibroblast-vækstfaktor)
2934 99 90
665058-78-6
DNA, d(T-sp-C-G-sp-T-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-G-sp-A-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-Gsp-T-sp-C-G-sp-T-sp-T)
2934 99 90
923591-06-4
methyl-(5R,7S,10S)-10-tert-butyl-15,15-dimethyl-3,9,12-trioxo-6,7,9,10,11,12,14,15,16,17,18,19-dodecahydro-1H,5H-2,23:5,8-dimethano-4,13,2,8,11-benzodioxatriazacyclohenicosin-7(3H)-carboxylat
2934 99 90
59337-92-7
methyl-3-(chlorsulfonyl)thiophen-2-carboxylat
2934 99 90
947409-01-0
methyl-3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(2-triphenylmethyl-1,2-benzisoxazol-3(2H)-on- 6-yl)methoxy]phenyl]propionat
2934 99 90
85006-31-1
methyl-3-amino-4-methylthiophen-2-carboxylat
2934 99 90
893428-72-3
N-(5-chlor-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamin – (2E)-2-butendioat (1:2)
2934 99 90
390800-88-1
N,N′,N′′-(boroxin-2,4,6-triyltris{[(1S)-3-methylbutan-1,1-diyl]imino[(2S)-1-oxo-3-phenylpropan-1,2-diyl]})tripyrazin-2-carboxamid
2934 99 90
112913-94-7
N-{[4-(4-fluorbenzyl)morpholin-2-yl]methyl}acetamid
2934 99 90
120788-03-6
S-[(1R,3S)-1-oxidotetrahydrothiophen-3-yl] ethanthioat
2935 00 90
1198178-65-2
(1R,2R)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethylcyclopropanaminium-4-methylbenzensulfonat
2935 00 90
39570-96-2
(2R)-3-(benzylsulfanyl)-N-[(2S)-1-{[(2S,3S)-1-hydrazinyl-3-methyl-1-oxopentan-2-yl]amino}-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-2-{[(4-methylphenyl)sulfonyl]amino}propanamid
2935 00 90
24310-36-9
1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-on
2935 00 90
0-00-0
2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinolin-7-sulfonamid-di[(2E)-but-2-endioat]-hydrat
2935 00 90
941690-55-7
3-[(methylsulfonyl)amino]-2-phenyl-N-[(1S)-1-phenylpropyl]quinolin-4-carboxamid
2935 00 90
6973-09-7
5-amino-2-methylbenzensulfonamid
2935 00 90
193686-76-9
7-chlor-1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-on
2935 00 90
123664-84-6
N-(5-methoxy-2-phenoxyphenyl)methansulfonamid
2935 00 90
149457-03-4
N-[4-(N-formylglycyl)-5-hydroxy-2-phenoxyphenyl]methansulfonamid
2935 00 90
149456-98-4
N-[4-(N-formylglycyl)-5-methoxy-2-phenoxyphenyl]methansulfonamid
2935 00 90
141450-48-8
N-{2-[(4-hydroxyphenyl)amino]pyridin-3-yl}-4-methoxybenzensulfonamidhydrochlorid
2935 00 90
289042-10-0
N-{5-[(diphenylphosphoryl)methyl]-4-(4-fluorphenyl)-6-(propan-2-yl)pyrimidin-2-yl}-N-methylmethansulfonamid
2939 99 00
7689-03-4
(4S)-4-ethyl-4-hydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-3,14(4H,12H)-dion
2939 99 00
477-29-2
colchicosid
2940 00 00
604-69-3
1,2,3,4,6-penta-O-acetyl-β-D-glucopyranose
2940 00 00
647834-15-9
2-(4-methoxybenzyl)thiophen-3-yl-β-D-glucopyranosid
2941 90 00
76610-92-9
(6R,7R)-7-({N-[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]-D-threonyl}amino)-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carboxylsyre
3907 20 99
913976-27-9
poly(oxy-1,2-ethandiyl), α-hydro-ω-methoxy, diester med 21N6, 21’N6-[[(N2, N6-dicarboxy-L-lysyl-β-alanyl)imino]bis(1-oxo-2, 1-ethandiyl)]bis[N-acetylglycyl-L-leucyl-L-tyrosyl-L-alanyl-L-cysteinyl-L-histidyl-L-methionylglycyl-L-prolyl-L-isoleucyl-L-threonyl-3-(1-naphthalenyl)-L-alanyl-L-valyl-L-cysteinyl-L-glutaminyl-L-prolyl-L-leucyl-L-arginyl-N-methylglycyl-L-lysinamid] cyklisk (6→15), (6’→15’) bis(disulfid)
BILAG IV
Liste over farmaceutiske mellemstoffer, dvs. stoffer, der bruges til fremstilling af farmaceutiske færdigvarer, der skal slettes på listen over produkter, der er fritaget for told, i bilag 6 til bilag I til forordning (EØF) nr. 2658/87, fordi de overføres til listen over produkter, der er fritaget for told, i bilag 3 til bilag I i forordning (EØF) 2658/87
KN-kode
CAS RN
Betegnelse
2915 39 00
2937 29 00
7753-60-8
17-alfa-hydroxy-3,20-dioxopregna-4,9(11)-dien-21-ylacetat
se anecortav (INN)
2920 90 85
163133-43-5
4-(nitrooxy)butyl-(2S)-2-(6-methoxy-2-naphthyl)propanoat
se naproxcinod (INN)
2924 29 98
194085-75-1
2-(2-chlorphenyl)-2-hydroxyethylcarbamat
se carisbamat (INN)
2933 39 99
103129-82-4
3-ethyl-5-methyl-2-[(2-aminoethoxy)methyl]-4-(2-chlorphenyl)-6-methyl-1,4-dihydropyridin-3,5-dicarboxylat
se levamlodipin (INN)
2933 39 99
319460-85-0
N-methyl-2-{[3-((E)-2-pyridin-2-ylvinyl)-1H-indazol-6-yl]sulfanyl}benzamid
se axitinib (INN)
2934 10 00
302962-49-8
N-(2-chlor-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)thiazol-5-carboxamid
se dasatinib (INN)
2934 99 90
143491-57-0
(2R,5S)-4-amino-5-fluor-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-on
se emtricitabin (INN)
2934 99 90
98819-76-2
(2S)-2-[(S)-(2-ethoxyphenoxy)phenylmethyl]morpholin
se esreboxetin (INN)
2934 99 90
475479-34-6
(2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propansyre
se aleglitazar (INN)
2934 99 90
377727-87-2
2-(2-furyl)-7-(2-{4-[4-(2-methoxyethoxy)phenyl]piperazin-1-yl}ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[2,3-c]pyrimidin-5-amin
se preladenant (INN)
2934 99 90
189003-92-7
2-{7-fluor-2-oxo-4-[2-(4-thieno[3,2-c]pyridin-4-ylpiperazin-1-yl)ethyl]quinolin-1(2H)-yl}acetamid
se trelanserin (INN)
2934 99 90
134379-77-4
4-amino-5-fluor-1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]pyrimidin-2(1H)-on
se dexelvucitabin (INN)
2934 99 90
518048-05-0
kalium-4-[N-(2-fluorbenzyl)carbamoyl]-1-methyl-2-[1-methyl-1-(5-methyl-1,3,4-oxadiazol-2-carboxamido)ethyl]-6-oxo-1,6-dihydropyrimidin-5-olat
se raltegravir (INN)
2935 00 90
170569-88-7
4-[5-(4-fluorphenyl)-3-(trifluormethyl)pyrazol-1-yl]benzen-1-sulfonamid
se mavacoxib (INN)
2935 00 90
186497-07-4
N-(3-methoxy-5-methylpyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridin-3-sulfonamid
se zibotentan (INN)

Summary:
Toldfri behandling af visse aktive farmaceutiske ingredienser 
RESUMÉ AF:
Forordning (EU) 
nr. 1238/2010
 – toldfri behandling af visse aktive farmaceutiske ingredienser og produkter, der anvendes til fremstilling af farmaceutiske færdigvarer
Forordning (EF) 
nr. 467/97
 – toldfri behandling af specificerede aktive ingredienser og produkter, der anvendes til fremstilling af farmaceutiske færdigvarer samt tilbagetrækning af denne behandling for andre ingredienser og produkter
HVAD ER FORMÅLET MED FORORDNINGERNE?
Ved forordningerne indarbejdes afgørelser om toldfri behandling af visse farmaceutiske produkter og aktive ingredienser i 
Den Europæiske Unions
 (EU) lovgivning. Disse blev først gang truffet i forbindelse med 
Uruguayrunden
 for forhandlinger om international samhandel.
Hver vare eller hvert produkt har et 
internationalt ikke-navnebeskyttet navn
 (INN)
1
, og nye varer og produkter er blevet tilføjet listerne ved flere lejligheder.
Forordning (EU) 
nr. 1238/2010
 opdaterer listerne efter den fjerde revision, som blev iværksat i 2009.
Forordning (EC) 
nr. 467/97
 opdaterer listerne efter den første revision.
HOVEDPUNKTER
Forordning (EU) 
nr. 1238/2010
Forordningen ændrer 
bilag I
 (lister over farmaceutiske stoffer kvalificeret til toldfri behandling) i forordning (EØF) 
nr. 
2658/87
 om EU’s 
kombinerede nomenklatur
.
Den sikrer toldfri behandling fra den 
1. januar 2011
 for:
produkter med internationale ikke-navnebeskyttede navne fra 
Verdenssundhedsorganisationens
 (bilag I)
listen over præfikser og suffikser
 der, kombineret med INN, beskriver salte, estere eller hydrater, som også er kvalificeret til toldfri behandling (bilag II)
farmaceutiske mellemstoffer
, der anvendes til produktion og fremstilling af farmaceutiske færdigvarer (bilag III).
Den fjerner visse farmaceutiske mellemstoffer fra listen over de stoffer, der modtager toldfri behandling (bilag IV).
Forordning (EF) 
nr. 467/97
Forordningen sikrer toldfri behandling fra den 
1. april 1997
 for:
231 angivne aktive farmaceutiske ingredienser
 med INN samt for deres salte, estere og hydrater (
bilag I
)
234 angivne produkter
, der anvendes til produktion og fremstilling af farmaceutiske færdigvarer (
bilag II
).
Den udvider listen over specifikke præfikser og suffikser for INN ved at tilføje 84 navne, der er berettiget til toldfri behandling (
bilag III
).
Den fjerner 25 produkter — samt deres salte, estere og hydrater — fra toldfri behandling, da de hovedsagelig anvendes til ikke-farmaceutiske formål (
bilag IV
).
HVORNÅR GÆLDER FORORDNINGERNE FRA?
Forordning (EU) 
nr. 1238/2010
 trådte i kraft den 
1. januar 2011
.
Forordning (EF) 
nr. 467/97
 trådte i kraft den 
14. marts 1997
.
BAGGRUND
Under Uruguayrunden blev de vigtigste producenter – EU, USA, Japan, Canada, Schweiz, Norge og Kina – enige om at reducere tolden på farmaceutiske produkter til nul. Aftalen omfattede mere end 6 000 produkter.
Af hensyn til udviklingen af nye lægemidler gennemførtes revisioner i 1995-1996, 1998 og 2006, hvor næsten 
2 400 produkter
 blev tilføjet. Ved den fjerde revision blev der tilføjet 718 nye stoffer, og dermed udgør det samlede antal toldfri farmaceutiske produkter, der importeres i EU, 
8 619
.
For yderligere oplysninger henvises til:
Program for internationale ikke-navnebeskyttede navne og klassifikation af medicinske produkter
 (Verdenssundhedsorganisationen).
VIGTIGE BEGREBER
Internationale ikke-navnebeskyttede navne (INN).
 Disse navne, der også kaldes almene betegnelser, identificerer farmaceutiske stoffer eller aktive farmaceutiske ingredienser. Hvert INN er et unikt navn, der er globalt anerkendt og klassificeret som offentlig ejendom. Verdenssundhedsorganisationen arbejder tæt sammen med INN-eksperter og nationale nomenklaturudvalg med henblik på at vælge ét specifikt navn for hvert aktivt stof, der accepteres på verdensplan, og som skal markedsføres som et farmaceutisk produkt.
HOVEDDOKUMENTER
Europa-Parlamentets og Rådets forordning (EU) 
nr 
1238/2010
 af 
15. december 2010
 om ændring af bilag I til Rådets forordning (EØF) 
nr. 2658/87
 for så vidt angår sikring af toldfri behandling af visse aktive farmaceutiske ingredienser med »internationale ikke-navnebeskyttede navne« (INN) fra Verdenssundhedsorganisationen og af visse produkter, der anvendes til fremstilling af farmaceutiske færdigvarer (EUT L 348 af 
31.12.2010
, 
s. 36-73
).
Rådets Forordning (EF) 
nr. 
467/97
 af 
3. marts 1997
 om sikring af toldfri behandling af specificerede aktive farmaceutiske ingredienser på WHO’s liste over »internationale ikke-navnebeskyttede navne« (INNs) og af specificerede varer, der anvendes til fremstilling af farmaceutiske færdigvarer samt tilbagetrækning af den toldfri behandling af visse INNs, som er indrømmet disse i egenskab af farmaceutiske varer, selv om de hovedsagelig anvendes til ikke-farmaceutiske formål (EUT L 71 af 
13.3.1997
, 
s. 1-15
).
TILHØRENDE DOKUMENTER
Rådets forordning (EØF) 
nr. 
2658/87
 af 
23. juli 1987
 om told- og statistiknomenklaturen og Den Fælles Toldtarif (EFT L 256 af 
7.9.1987
, 
s. 1-675
).
Efterfølgende ændringer af forordning (EØF) 
nr. 2658/87
 er blevet indarbejdet i grundteksten. Denne 
konsoliderede udgave
 har ingen retsvirkning.
seneste ajourføring 
14.12.2021